| MeSH term | MeSH ID | Detail |
|---|---|---|
| Atherosclerosis | D050197 | 85 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
2,3-dinor, 6-keto-PGF1alpha
2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 782 references associated with 2,3-dinor, 6-keto-PGF1alpha in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 2,3-dinor, 6-keto-PGF1alpha
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
NCBI Entrez Crosslinks
All references with 2,3-dinor, 6-keto-PGF1alpha
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Mills JL et al. | Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. | 1999 | JAMA | pmid:10432033 |
| Stichtenoth DO et al. | Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers. | 2005 | Kidney Int. | pmid:16221219 |
| Edlund A et al. | Myocardial ischaemia triggers formation of thromboxane. | 1987 | Lancet | pmid:2887865 |
| Gréen K et al. | Deficient prostacyclin formation after acute myocardial infarction. | 1987 | Lancet | pmid:2883378 |
| Watson ML et al. | Systemic prostaglandin I2 synthesis is normal in patients with Bartter's syndrome. | 1983 | Lancet | pmid:6135873 |
| Liggins GC et al. | Prostacyclin and maternal lupus anticoagulant. | 1984 | Lancet | pmid:6140483 |
| Tulppala M et al. | Thromboxane dominance and prostacyclin deficiency in habitual abortion. | 1991 | Lancet | pmid:1672969 |
| Falardeau P and Brash AR | Quantitation of two dinor metabolites of prostacyclin by GC-MS. | 1982 | Meth. Enzymol. | pmid:6752645 |
| Fitzgerald DJ et al. | Platelet activation in unstable coronary disease. | 1986 | N. Engl. J. Med. | pmid:3531859 |
| Alessandrini P et al. | Thromboxane biosynthesis and platelet function in type I diabetes mellitus. | 1988 | N. Engl. J. Med. | pmid:3292913 |
| Christman BW et al. | An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. | 1992 | N. Engl. J. Med. | pmid:1603138 |
| FitzGerald GA et al. | Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. | 1984 | N. Engl. J. Med. | pmid:6231483 |
| Knapp HR et al. | In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. | 1986 | N. Engl. J. Med. | pmid:3007982 |
| Goldberg MR et al. | Prostacyclin biosynthesis and platelet function in autonomic dysfunction. | 1985 | Neurology | pmid:3838109 |
| Yuhki K et al. | [Prostaglandin I2 and its metabolites]. | 2010 | Nippon Rinsho | pmid:20960743 |
| Ylikorkala O et al. | Urinary prostacyclin and thromboxane metabolites in drinking pregnant women and in their infants: relations to the fetal alcohol effects. | 1988 | Obstet Gynecol | pmid:3275910 |
| Rauramo I et al. | Prostacyclin and thromboxane in pregnant and nonpregnant women in response to exercise. | 1995 | Obstet Gynecol | pmid:7770249 |
| Saareks V et al. | Opposite effects of nicotinic acid and pyridoxine on systemic prostacyclin, thromboxane and leukotriene production in man. | 2002 | Pharmacol. Toxicol. | pmid:12403056 |
| McAdam BF et al. | Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. | 1999 | Proc. Natl. Acad. Sci. U.S.A. | pmid:9874808 |
| Praticò D et al. | Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. | 2001 | Proc. Natl. Acad. Sci. U.S.A. | pmid:11248083 |